|

RC148 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • RemeGen Co., Ltd.2

Indications

  • Cancer2
  • Advanced Solid Tumor1
  • Breast Cancer1

Other2 trials

A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors
Phase 1/2
Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ± Toripalimab in HR-/HER2-low Breast Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.